Global Pharmaceutical Anti-Counterfeiting Technologies Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 98

Report ID: 39110

Counterfeit medicines are manufactured by contaminating or using the wrong compounds with no active ingredient. These are drugs are illegal and pose a significant health risks. Thus, anti-counterfeiting technologies play a pivotal role in the identification of fake medicines. These technologies are highly adopted in the pharmaceutical industries to avoid substantial public health hazards. The factors that fuel the growth of the global pharmaceutical anti-counterfeiting technologies market are rise in availability of counterfeited pharmaceuticals and increase in government initiatives to spread awareness regarding fake medicines. However, lack of awareness towards anti-counterfeiting technologies in the developing economies is anticipated to restrain the market growth. Conversely, technological advancements in pharmaceutical anti-counterfeiting technologies are anticipated to offer lucrative opportunities for the expansion of the market.
In 2018, the global Pharmaceutical Anti-Counterfeiting Technologies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Pharmaceutical Anti-Counterfeiting Technologies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceutical Anti-Counterfeiting Technologies development in United States, Europe and China.

The key players covered in this study
3M Company
Alien Technology
Alpvision
Angstrom Technologies
ThermoFisher Scientific
Authentix, Inc.
Avery Dennison Corporation
Colorcon
Covectra
Everest Holovisions Ltd.

Market segment by Type, the product can be split into
Barcodes
Radiofrequency Identification (RFID)
Holograms/OVD
Taggants
Others

Market segment by Application, split into
Authentication Technology
Track & Trace Technology

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Pharmaceutical Anti-Counterfeiting Technologies status, future forecast, growth opportunity, key market and key players.
To present the Pharmaceutical Anti-Counterfeiting Technologies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Pharmaceutical Anti-Counterfeiting Technologies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pharmaceutical Anti-Counterfeiting Technologies Market Size Growth Rate by Type (2014-2025)
1.4.2 Barcodes
1.4.3 Radiofrequency Identification (RFID)
1.4.4 Holograms/OVD
1.4.5 Taggants
1.4.6 Others
1.5 Market by Application
1.5.1 Global Pharmaceutical Anti-Counterfeiting Technologies Market Share by Application (2014-2025)
1.5.2 Authentication Technology
1.5.3 Track & Trace Technology
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Pharmaceutical Anti-Counterfeiting Technologies Market Size
2.2 Pharmaceutical Anti-Counterfeiting Technologies Growth Trends by Regions
2.2.1 Pharmaceutical Anti-Counterfeiting Technologies Market Size by Regions (2014-2025)
2.2.2 Pharmaceutical Anti-Counterfeiting Technologies Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Pharmaceutical Anti-Counterfeiting Technologies Market Size by Manufacturers
3.1.1 Global Pharmaceutical Anti-Counterfeiting Technologies Revenue by Manufacturers (2014-2019)
3.1.2 Global Pharmaceutical Anti-Counterfeiting Technologies Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Pharmaceutical Anti-Counterfeiting Technologies Market Concentration Ratio (CR5 and HHI)
3.2 Pharmaceutical Anti-Counterfeiting Technologies Key Players Head office and Area Served
3.3 Key Players Pharmaceutical Anti-Counterfeiting Technologies Product/Solution/Service
3.4 Date of Enter into Pharmaceutical Anti-Counterfeiting Technologies Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Pharmaceutical Anti-Counterfeiting Technologies Market Size by Type (2014-2019)
4.2 Global Pharmaceutical Anti-Counterfeiting Technologies Market Size by Application (2014-2019)

5 United States
5.1 United States Pharmaceutical Anti-Counterfeiting Technologies Market Size (2014-2019)
5.2 Pharmaceutical Anti-Counterfeiting Technologies Key Players in United States
5.3 United States Pharmaceutical Anti-Counterfeiting Technologies Market Size by Type
5.4 United States Pharmaceutical Anti-Counterfeiting Technologies Market Size by Application

6 Europe
6.1 Europe Pharmaceutical Anti-Counterfeiting Technologies Market Size (2014-2019)
6.2 Pharmaceutical Anti-Counterfeiting Technologies Key Players in Europe
6.3 Europe Pharmaceutical Anti-Counterfeiting Technologies Market Size by Type
6.4 Europe Pharmaceutical Anti-Counterfeiting Technologies Market Size by Application

7 China
7.1 China Pharmaceutical Anti-Counterfeiting Technologies Market Size (2014-2019)
7.2 Pharmaceutical Anti-Counterfeiting Technologies Key Players in China
7.3 China Pharmaceutical Anti-Counterfeiting Technologies Market Size by Type
7.4 China Pharmaceutical Anti-Counterfeiting Technologies Market Size by Application

8 Japan
8.1 Japan Pharmaceutical Anti-Counterfeiting Technologies Market Size (2014-2019)
8.2 Pharmaceutical Anti-Counterfeiting Technologies Key Players in Japan
8.3 Japan Pharmaceutical Anti-Counterfeiting Technologies Market Size by Type
8.4 Japan Pharmaceutical Anti-Counterfeiting Technologies Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Pharmaceutical Anti-Counterfeiting Technologies Market Size (2014-2019)
9.2 Pharmaceutical Anti-Counterfeiting Technologies Key Players in Southeast Asia
9.3 Southeast Asia Pharmaceutical Anti-Counterfeiting Technologies Market Size by Type
9.4 Southeast Asia Pharmaceutical Anti-Counterfeiting Technologies Market Size by Application

10 India
10.1 India Pharmaceutical Anti-Counterfeiting Technologies Market Size (2014-2019)
10.2 Pharmaceutical Anti-Counterfeiting Technologies Key Players in India
10.3 India Pharmaceutical Anti-Counterfeiting Technologies Market Size by Type
10.4 India Pharmaceutical Anti-Counterfeiting Technologies Market Size by Application

11 Central & South America
11.1 Central & South America Pharmaceutical Anti-Counterfeiting Technologies Market Size (2014-2019)
11.2 Pharmaceutical Anti-Counterfeiting Technologies Key Players in Central & South America
11.3 Central & South America Pharmaceutical Anti-Counterfeiting Technologies Market Size by Type
11.4 Central & South America Pharmaceutical Anti-Counterfeiting Technologies Market Size by Application

12 International Players Profiles
12.1 3M Company
12.1.1 3M Company Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pharmaceutical Anti-Counterfeiting Technologies Introduction
12.1.4 3M Company Revenue in Pharmaceutical Anti-Counterfeiting Technologies Business (2014-2019)
12.1.5 3M Company Recent Development
12.2 Alien Technology
12.2.1 Alien Technology Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pharmaceutical Anti-Counterfeiting Technologies Introduction
12.2.4 Alien Technology Revenue in Pharmaceutical Anti-Counterfeiting Technologies Business (2014-2019)
12.2.5 Alien Technology Recent Development
12.3 Alpvision
12.3.1 Alpvision Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pharmaceutical Anti-Counterfeiting Technologies Introduction
12.3.4 Alpvision Revenue in Pharmaceutical Anti-Counterfeiting Technologies Business (2014-2019)
12.3.5 Alpvision Recent Development
12.4 Angstrom Technologies
12.4.1 Angstrom Technologies Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pharmaceutical Anti-Counterfeiting Technologies Introduction
12.4.4 Angstrom Technologies Revenue in Pharmaceutical Anti-Counterfeiting Technologies Business (2014-2019)
12.4.5 Angstrom Technologies Recent Development
12.5 ThermoFisher Scientific
12.5.1 ThermoFisher Scientific Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pharmaceutical Anti-Counterfeiting Technologies Introduction
12.5.4 ThermoFisher Scientific Revenue in Pharmaceutical Anti-Counterfeiting Technologies Business (2014-2019)
12.5.5 ThermoFisher Scientific Recent Development
12.6 Authentix, Inc.
12.6.1 Authentix, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Pharmaceutical Anti-Counterfeiting Technologies Introduction
12.6.4 Authentix, Inc. Revenue in Pharmaceutical Anti-Counterfeiting Technologies Business (2014-2019)
12.6.5 Authentix, Inc. Recent Development
12.7 Avery Dennison Corporation
12.7.1 Avery Dennison Corporation Company Details
12.7.2 Company Description and Business Overview
12.7.3 Pharmaceutical Anti-Counterfeiting Technologies Introduction
12.7.4 Avery Dennison Corporation Revenue in Pharmaceutical Anti-Counterfeiting Technologies Business (2014-2019)
12.7.5 Avery Dennison Corporation Recent Development
12.8 Colorcon
12.8.1 Colorcon Company Details
12.8.2 Company Description and Business Overview
12.8.3 Pharmaceutical Anti-Counterfeiting Technologies Introduction
12.8.4 Colorcon Revenue in Pharmaceutical Anti-Counterfeiting Technologies Business (2014-2019)
12.8.5 Colorcon Recent Development
12.9 Covectra
12.9.1 Covectra Company Details
12.9.2 Company Description and Business Overview
12.9.3 Pharmaceutical Anti-Counterfeiting Technologies Introduction
12.9.4 Covectra Revenue in Pharmaceutical Anti-Counterfeiting Technologies Business (2014-2019)
12.9.5 Covectra Recent Development
12.10 Everest Holovisions Ltd.
12.10.1 Everest Holovisions Ltd. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Pharmaceutical Anti-Counterfeiting Technologies Introduction
12.10.4 Everest Holovisions Ltd. Revenue in Pharmaceutical Anti-Counterfeiting Technologies Business (2014-2019)
12.10.5 Everest Holovisions Ltd. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details